Cargando…

Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss

Alzheimer's disease (AD) is the most prevalent age‐related neurodegenerative disorder, affecting over 35 million people worldwide. Pathologically, AD is characterized by the progressive accumulation of β‐amyloid (Aβ) plaques and neurofibrillary tangles within the brain. Together, these patholog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ager, Rahasson R., Davis, Joy L., Agazaryan, Andy, Benavente, Francisca, Poon, Wayne W., LaFerla, Frank M., Blurton‐Jones, Mathew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722865/ https://www.ncbi.nlm.nih.gov/pubmed/25530343 http://dx.doi.org/10.1002/hipo.22405

Ejemplares similares

Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models
por: Blurton-Jones, Mathew, et al.
Publicado: (2014)

Soluble Amyloid Precursor Protein Induces Rapid Neural Differentiation of Human Embryonic Stem Cells
por: Freude, Kristine K., et al.
Publicado: (2011)

Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer's disease
por: Baglietto‐Vargas, David, et al.
Publicado: (2018)

Tau underlies synaptic and cognitive deficits for type 1, but not type 2 diabetes mouse models
por: Trujillo‐Estrada, Laura, et al.
Publicado: (2019)

HuCNS-SC Human NSCs Fail to Differentiate, Form Ectopic Clusters, and Provide No Cognitive Benefits in a Transgenic Model of Alzheimer's Disease
por: Marsh, Samuel E., et al.
Publicado: (2017)

Hippocampal Adaptive Response Following Extensive Neuronal Loss in an Inducible Transgenic Mouse Model
por: Myczek, Kristoffer, et al.
Publicado: (2014)

Multiple Events Lead to Dendritic Spine Loss in Triple Transgenic Alzheimer's Disease Mice
por: Bittner, Tobias, et al.
Publicado: (2010)

Reply to Peng and Zhao: Loss of endocytic protein TOM1 in Alzheimer’s disease
por: Martini, Alessandra C., et al.
Publicado: (2020)

SPG302 Reverses Synaptic and Cognitive Deficits Without Altering Amyloid or Tau Pathology in a Transgenic Model of Alzheimer’s Disease
por: Trujillo-Estrada, Laura, et al.
Publicado: (2021)

Impaired Adult Neurogenesis in the Dentate Gyrus of a Triple Transgenic Mouse Model of Alzheimer's Disease
por: Rodríguez, José J., et al.
Publicado: (2008)

Spatial coding defects of hippocampal neural ensemble calcium activities in the triple-transgenic Alzheimer’s disease mouse model
por: Lin, Xiaoxiao, et al.
Publicado: (2022)

Amyloid-beta impairs TOM1-mediated IL-1R1 signaling
por: Cadete Martini, Alessandra, et al.
Publicado: (2019)

Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice
por: Janelsins, Michelle C, et al.
Publicado: (2005)

7,8-Dihydroxyflavone, a Small Molecule TrkB Agonist, Improves Spatial Memory and Increases Thin Spine Density in a Mouse Model of Alzheimer Disease-Like Neuronal Loss
por: Castello, Nicholas A., et al.
Publicado: (2014)

Treatment of Alzheimer's Disease with Anti-Homocysteic Acid Antibody in 3xTg-AD Male Mice
por: Hasegawa, Tohru, et al.
Publicado: (2010)

Neuron Loss in Transgenic Mouse Models of Alzheimer's Disease
por: Wirths, Oliver, et al.
Publicado: (2010)

Intra- and extracellular β-amyloid overexpression via adeno-associated virus-mediated gene transfer impairs memory and synaptic plasticity in the hippocampus
por: Forner, Stefania, et al.
Publicado: (2019)

Neural Stem Cells Rescue Cognitive and Motor Dysfunction in a Transgenic Model of Dementia with Lewy Bodies through a BDNF-Dependent Mechanism
por: Goldberg, Natalie R.S., et al.
Publicado: (2015)

Formulation of a Medical Food Cocktail for Alzheimer's Disease: Beneficial Effects on Cognition and Neuropathology in a Mouse Model of the Disease
por: Parachikova, Anna, et al.
Publicado: (2010)

Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models
por: Wirths, Oliver, et al.
Publicado: (2020)

Synaptic Loss in Alzheimer's Disease: Mechanistic Insights Provided by Two-Photon in vivo Imaging of Transgenic Mouse Models
por: Subramanian, Jaichandar, et al.
Publicado: (2020)

miR‐181a negatively modulates synaptic plasticity in hippocampal cultures and its inhibition rescues memory deficits in a mouse model of Alzheimer’s disease
por: Rodriguez‐Ortiz, Carlos J., et al.
Publicado: (2020)

In vivo optical signatures of neuronal death in a mouse model of Alzheimer's disease
por: Lin, Alexander J, et al.
Publicado: (2014)

BrightFocus Alzheimer’s Fast Track 2019
por: Whitaker, Keith W., et al.
Publicado: (2019)

MTH1 and OGG1 maintain a low level of 8-oxoguanine in Alzheimer's brain, and prevent the progression of Alzheimer's pathogenesis
por: Oka, Sugako, et al.
Publicado: (2021)

Compensating for thalamocortical synaptic loss in Alzheimer's disease
por: Abuhassan, Kamal, et al.
Publicado: (2014)

Changes in neuronal excitability and synaptic transmission in nucleus accumbens in a transgenic Alzheimer’s disease mouse model
por: Fernández-Pérez, E. J., et al.
Publicado: (2020)

Human mitochondrial transcriptional factor A breaks the mitochondria-mediated vicious cycle in Alzheimer’s disease
por: Oka, Sugako, et al.
Publicado: (2016)

Consumption of pomegranates improves synaptic function in a transgenic mice model of Alzheimer's disease
por: Braidy, Nady, et al.
Publicado: (2016)

Pinpointing Synaptic Loss Caused by Alzheimer’s Disease with fMRI
por: Brickman, Adam M., et al.
Publicado: (2009)

Intracellular Accumulation of Amyloid-Beta – A Predictor for Synaptic Dysfunction and Neuron Loss in Alzheimer's Disease
por: Bayer, Thomas A., et al.
Publicado: (2010)

Genetic Knockdown of Brain-Derived Neurotrophic Factor in 3xTg-AD Mice Does Not Alter Aβ or Tau Pathology
por: Castello, Nicholas A., et al.
Publicado: (2012)

DL0410 ameliorates cognitive deficits in APP/PS1 transgenic mice by promoting synaptic transmission and reducing neuronal loss
por: Zhou, Wei, et al.
Publicado: (2019)

Sex Differences between Neuronal Loss and the Early Onset of Amyloid Deposits and Behavioral Consequences in 5xFAD Transgenic Mouse as a Model for Alzheimer’s Disease
por: Poon, Chi Him, et al.
Publicado: (2023)

Impaired Spatial Reorientation in the 3xTg-AD Mouse Model of Alzheimer’s Disease
por: Stimmell, Alina C., et al.
Publicado: (2019)

Altered Expression of Diabetes-Related Genes in Alzheimer's Disease Brains: The Hisayama Study
por: Hokama, Masaaki, et al.
Publicado: (2014)

Human neural cell type‐specific extracellular vesicle proteome defines disease‐related molecules associated with activated astrocytes in Alzheimer's disease brain
por: You, Yang, et al.
Publicado: (2022)

Spatial Frequency Domain Imaging of Intrinsic Optical Property Contrast in a Mouse Model of Alzheimer’s Disease
por: Lin, Alexander J., et al.
Publicado: (2011)

The TNFα-Transgenic Rat: Hippocampal Synaptic Integrity, Cognition, Function, and Post-Ischemic Cell Loss
por: Pettigrew, L. Creed, et al.
Publicado: (2016)

Transgenic FingRs for Live Mapping of Synaptic Dynamics in Genetically-Defined Neurons
por: Son, Jong-Hyun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pg1hrlqce5oceu7n46v42r9kj2